A Whole Body Approach to Cardiometabolic Care with 9am Health

We are excited for the fresh infusion of $16M in Series A capital for 9am Health, led by 7Wire Ventures and Human Capital, with continued participation from Define Ventures and Founders Fund. Our investment in the Series A comes just a year after we co-led 9am Health’s Series Seed fundraise in April 2021.

Prediabetes and diabetes affect nearly 100 million Americans. These 100 million Americans lead busy lives and deserve to manage their health seamlessly without sacrificing time, energy, and resources through an accessible virtual care model. This comprehensive approach provides patients everything they need to successfully manage their condition, including at-home diagnostic labs, blood glucose monitoring kits, and medication delivered to their doorstep surrounded by consumer-centric providers who practice an empathy-first approach to delivering care.

We believe that consumers have chosen to take active control of their health in the wake of COVID, unconstrained by location, time, or mode of care; chronic care in particular needs to incorporate those principles as well. The founders of 9am Health have espoused these ideals over and over again, starting from the founding of MySugr, which they sold to Roche in 2017 through their work today. Co-CEOs and Co-Founders Frank Westermann and Anton Kittelberger both live with diabetes and deeply understand not only the shortfalls of the current system, but also the needs of the individuals they serve.

This new round of funding will help 9am Health accelerate its direct-to-consumer efforts, grow rapidly to support the increased demand from self-insured employers, and expand its medical device integrations and platform partner relationships. We’ve partnered closely with 9am Health from the very beginning to support their go-to-market strategy, UI/UX, and brand development; build partnerships with channel partners and market influencers; provide recruiting support across marketing, growth, and product; and serve as a thought partner throughout:

“As an early stage company you want an investor who really rolls up their sleeves and supports you. That’s Define Ventures. No matter if it’s an operative or strategic question and no matter what time of day or day of the week, Define is always there to support us. As a founder you couldn’t ask for more.” — Frank Westermann, CEO & Co-Founder, 9am Health

9am Health is empowering consumers to be defined by who they are and not their chronic conditions; it’s our privilege to be a part of that mission and build alongside this seasoned and savvy team. In a dynamic and evolving world where chronic disease is both a clinical and logistical burden, we could not be more excited or proud about the impact this team can have for hundreds of millions of people.

related Insights